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1. INTRODUCTION 
As legume grains are the major group of agricultural commodities, which are 
widely grown and consumed globally. With increasing evidence of natural benefits, they 
are also potentially sources of novel ingredients including starches. Present day consumer’s 
looks for natural ingredients in foods, drugs and cosmetics as they trust that anything 
natural will be more safe and free from side effects. Most of the natural ingredients used in 
the food industries and pharmaceutical industries are regarded as safe for human 
consumption [1, 2]. 
Solid dosage forms like tablets and capsules are the most popular and preferred 
drug delivery systems because they have high patient compliance, relatively easy to 
produce, easy to market, accurate dosing and good physical and chemical stability. Tablet 
dosage form is mainly composed of the drug and the excipients. The excipients have a 
direct influence on the quality and effectiveness of the final product [3, 4 and 5].  
Natural excipients are inert, safe, non-toxic, biocompatible, biodegradable, low 
cost, eco-friendly and abundantly available in nature. Although excipients are termed as 
inert, they have a large influence on stability, bioavailability and the process by which the 
dosage forms are prepared. Starch is most widely used one of the excipients in food as well 
as pharmaceutical industries, where they are used as binders, fillers, thickeners, glidants, 
disintegrants as well as gelling, bulking and water retention agent. Marketable starches are 
obtained from cereals such as corn, wheat and from roots and tubers particularly potato, 
cassava and they lead the world markets for starches in the food and pharmaceutical 
industries [6, 7 and 8].  
Recently more attention has been focused on the development of some of the 
starches from different botanical sources as excipients in pharmaceutical formulation. With 
the versatility of starch in various dosage forms, there is a need to continue to develop a 
prudent choice of starch excipients with suitable properties to meet the special needs of 
drug formulators. Lot of studies showed the nutritional value of the edible varieties of 
pulses, and more studies even showed disease curing or therapeutic properties of legumes, 
As legumes are fiber rich starchy vegetables that improve blood sugar control and reduce 
cardiovascular risk in diabetics, that there is a need still exists to examine the various 
pharmaceutical properties of the starch isolated from the seeds of Pisum sativum and Cicer 
arietinum to assess its functionality as pharmaceutical excipients [9, 10 and 11]. 
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1.1 Diabetes:  
Diabetes is a chronic disease that occurs when adequate insulin was not 
produced by the pancreas, or when the body cannot efficiently use the insulin it produces. 
Hyperglycemia is a common effect of uncontrolled diabetes and at last leads to serious 
damage to most of the body's systems, mainly the nerves and blood vessels. 
The most common forms of diabetes are as follows; 
 Type 1 diabetes, 
 Type 2 diabetes, and 
 Gestational diabetes. 
 1.1.1 Diabetes in world [12, 13]: 
                  Diabetes can be found in every country in the world and the burden will 
continue to increase globally due to lack of effective prevention and management 
programmes. Type 2 diabetes (85 to 95%) is now a common as well as serious global 
health problem for most of the countries. 
As per the latest estimate of International Diabetes Federation (IDF) 2012; 
 More than 371 million people worldwide have diabetes. 
 Half of people with diabetes are undiagnosed. 
 4.8 million Peoples died due to diabetes. 
   
Source: IDF DIABETES ATLAS (Update 2012) 12 
 
 
Introduction 
Department of Pharmaceutics, KMCH College of Pharmacy, Coimbatore.  Page 3 
 
 
IDF DIABETES ATLAS 2012 UPDATE12 
 
 
 
Source: IDF DIABETES ATLAS (Update 2012) 12 
 
 
 
Figure 1.01: International Diabetes Federation Atlas Update 2012 
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1.1.2 Diabetes in India14: 
According to the International Diabetes Federation (IDF), India has 70 million 
diabetics between 20-79 years. Major numbers of diabetics were found in middle and low 
income countries. In fact by 2030, according to the estimates, 8.4 percent of India’s adult 
population will have diabetes, but the bigger worry is the numbers that go undiagnosed. 
The risk factors for diabetes in Indians are; 
 Age 
 Family History 
 Central Obesity 
 Physical Inactivity and Sedentary Living 
 Insulin Resistance 
 Urbanization 
 Stress 
1.2 Cereals and pulses [15, 16]: 
Cereals and pulses are the two main grain group crops that are grown in 
different parts of the world. These two crop groups are regularly consumed by most of the 
world population. Some part of the world might favour one over the other, but often they 
are consumed in combination. 
Table 1.01: A comparison of world production of cereals, pulses and roots & tubers in 
year 2012 
 Grouping of Commodities 
Production quantity (tonnes) in year 2012 
World  India 
01. Cereals, Total 2,546,631,494 286,500,000 
02. Pulses, Total 70,418,680 16,280,000 
03. Roots and Tubers, Total 805,824,378 54,176,000 
Source: Food and Agriculture Organization of the United Nations (FAOSTAT)17 
1.2.1 Legumes18: 
The term “legume” refers to the plants whose fruit is enclosed in a pod. 
Legumes represent a huge family of plants together with more than 600 genera and more 
than 13,000 species. While growing, legumes fix nitrogen into the soil, which reduces the 
need for chemical fertilizers. Well-known legumes include alfalfa, clover, fresh peas, 
lupins, mesquite, soy and peanuts. 
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1.2.2 Pulses [15, 16 and 18]: 
Pulses are part of the legume family, but the term “pulse” refers only to the 
dried seed. Dried peas, edible beans, lentils and chickpeas are the most common varieties 
of pulses. They have important nutritional and health advantages for consumers. Pulses are 
consumed for proteins and slow release carbohydrates especially starch. Most of the pulses 
are rich in complex carbohydrates and have a total carbohydrate content ranging from 24 to 
68% on dry weight basis. Pulses elicit the lowest blood glucose response. Several reports 
claim that inclusion of pulses in the daily diet has several beneficial physiological effects 
in controlling and preventing various metabolic diseases such as diabetes mellitus, 
coronary heart disease and colon cancer. The role of pulses gains more importance among 
the people suffering from metabolic disorder. 
Table 1.02: World Pulses Production 2012 
World Pulses Production 2012 
Production (tonnes) 
Country Item 2012 
 
 
 
 
 
World + (Total) 
Bambara beans 150,500 
Beans, dry 23,140,276 
Broad beans, horse beans, 
dry 
4,057,922 
Chick peas 11,308,684 
Cow peas, dry 5,737,836 
Lentils 4,550,358 
Lupins 1,290,656 
Peas, dry 9,861,758 
Pigeon peas 4,329,078 
Pulses, nes 5,049,539 
Vetches 942,074 
Pulses, Total + (Total) 70,418,680 
Source: Food and Agriculture Organization of the United Nations (FAOSTAT)17 
Table 1.03: India Pulses Production 2012 
India Pulses Production 2012 
Production (tonnes) 
Country Item 2012 
 
 
 
India + (Total) 
Beans, dry 3,630,000 
Chick peas 7,700,000 
Lentils 950,000 
Peas, dry 625,000 
Pigeon peas 2,650,000 
Pulses, nes 725,000 
Pulses, Total + (Total) 16,280,000 
Source: Food and Agriculture Organization of the United Nations (FAOSTAT)17 
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1.2.3 Chickpea [19, 20]: 
Chickpea (Cicer arietinum L.), also called as Bengal gram or garbanzo bean, is 
an old world pulse and one of the seven Neolithic founder crops in the fertile crescent of 
near east19. Currently, chickpea is grown in over 50 countries around the world. Globally, 
chickpea is the third most important pulse crop in production, next to dry beans and field 
pea20. India is the largest producer and consumer of chickpeas in the world, while in 2012-
13 (second advance estimates) record production of chickpea is 8567.8 thousand tonnes21. 
 
 
Figure 1.02: Flowering and fruiting chickpea plant and chickpea pods. 
 
Table 1.04: Scientific Classification of Chickpea: 
Scientific Classification 
 Chick pea 
Cicer arietinum L. 
Rank Scientific Name & Common Name 
Kingdom Plantae – Plants 
Subkingdom Tracheobionta – Vascular plants 
Super division Spermatophyta – Seed plants 
Division Magnoliophyta – Flowering plants 
Class Magnoliopsida – Dicotyledons 
Subclass Rosidae 
Order Fabales 
Family Fabaceae – Pea family 
Genus Cicer L. - cicer 
Species Cicer arietinum L. – chick pea 
Source : United States Department of Agriculture (USDA) 
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Table 1.05: World Chickpea Production: 
World Chickpea Production 
Top 10 Destinations by Crop Year 
 2011 
                                            Tonnes 
2012 
                                            tonnes 
 World + (Total) 11,609,723 World + (Total) 11,308,684 
01. India 8,220,000 India 7,700,000 
02. Australia 513,338 Australia 673,371 
03. Pakistan 496,000 Turkey 535,000 
04. Turkey 487,477 Myanmar 473,102 
05. Myanmar 473,102 Ethiopia 400,207 
06. Ethiopia 322,829 Iran 315,000 
07. Iran 290,243 Pakistan 291,000 
08. United states of America 99,881 Canada 157,280 
09. Canada 90,800 United states of America 150,638 
10. Mexico 72,143 United republic of Tanzania 74,000 
Source: Food and Agriculture Organization of the United Nations (FAOSTAT)17 
Globally, chickpea is mostly consumed as a seed food in several different forms 
and preparations. These different forms of consumption provide consumers with valuable 
nutrition and potential health benefits. There are two different types of cultivated chickpea, 
Desi and Kabuli. The Desi types report for about 80-85% of the total chickpea area and are 
typically grown in Asia and Africa. The Kabuli types are mainly grown in West Asia, 
North Africa, North America and Europe. There is a growing demand for chickpea due to 
its nutritional value20. 
Chickpeas have been and are being consumed by humans since ancient times. 
Despite chickpea being a member of the “founder crop package” with potential 
nutritional/medicinal qualities, it has not received as much as necessary attention for 
research like other founder crops (e.g. wheat). Although publications have described the 
physicochemical and nutritional characteristics of chickpea, there is limited information 
relating to the starch and its pharmaceutical uses. So there is a need to isolate starch from 
chickpea and examine their various pharmaceutical properties to assess its functionality as 
pharmaceutical binder.  
 
1.2.4 Dry Pea [9, 11]: 
Dry pea (Pisum sativum L.), also called as Garden pea, green pea or field pea, is 
now grown all over the world and are widely consumed in both dried and fresh form. The 
green pea is widely accepted as one of the first food crops to be cultivated by humans. 
Canada is currently the largest world producer and exporter of peas. Russia, china, India 
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and France are also large scale producer of this legume. Even though being a large-scale 
producer of peas, India is also the world’s largest importer of this food due to its vast 
popularity in that country11. 
Peas are starchy vegetables that are rich in fiber, which helps to lower 
cholesterol, reduces your risk of type-2 diabetes and keeps you feeling full, by this means 
helping with weight loss. As a good source of Folate and Vitamin-B, they may help to 
reduce the risk of cardiovascular disease. Peas also supply vitamin C, which helps to keep 
skin, hair and eyes healthy and Vitamin-K, which some research suggests may help to 
preserve bone health9. 
 
     
Figure 1.03: Flowering and fruiting Green pea plant and Green pea pods. 
 
 
Table 1.06: Scientific Classification of Dry Pea: 
Scientific Classification 
 Dried pea 
Pisum sativum L. 
Rank Scientific Name & Common Name 
Kingdom Plantae – Plants 
Subkingdom Tracheobionta – Vascular plants 
Super division Spermatophyta – Seed plants 
Division Magnoliophyta – Flowering plants 
Class Magnoliopsida – Dicotyledons 
Subclass Rosidae 
Order Fabales 
Family Fabaceae – Pea family 
Genus Pisum L. – pea 
Species Pisum sativum L. – green pea 
Source : United States Department of Agriculture (USDA) 
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Table 1.07: World Dry Pea Production: 
World Dry Pea Production 
Top 10 Destinations by Crop Year 
 2011 
                                                     tonnes 
2012 
                                                      Tonnes 
 World + (Total) 9,729,673 World + (Total) 9,861,758 
01. Canada 2,115,600 Canada 2,803,000 
02. Russian federation 2,021,000 Russian federation 1,660,016 
03. China 1,190,000 China 1,114,000 
04. France 670,079 India  625,000 
05. India 593,200 France 565,322 
06. Australia 394,675 United states of America 493,150 
07. Ukraine 364,300 Ukraine 351,400 
08. Ethiopia 257,031 Australia 342,500 
09. United states of America 255,150 Ethiopia 263,266 
10. Spain 253,427 Germany 139,000 
Source: Food and Agriculture Organization of the United Nations (FAOSTAT)17 
Pea starch is widely used in the food industry because of its excellent 
thickening and binding properties and also its ability to optimize the gelling process. 
Several manufacturers use starch made from peas especially when producing meat and 
dairy products. Though, pea starch is popular in food industry due to their nutritional 
properties, there is a need still exists to examine various pharmaceutical properties of the 
starch to assess its functionality as pharmaceutical binder. 
1.2.5 Comparison of Chickpea and Dried peas: 
   Chickpeas and Dried peas are the rich source of ‘lente’ carbohydrates, which 
provides several beneficial physiological effects. In recent years, glycemic index (GI) has 
became a useful tool for planning diets for the patients of diabetes, dyslipidemia, 
cardiovascular disease, and even certain cancers in the general population.      
                                                                         
   
  Figure 1.04: Chickpea (whole, dried, raw) 22         Figure 1.05: Pea (whole, dried, raw) 23 
 
10.40%
20%
61.50%
5.20% 2.90%
General Components
Water
Protein
Carbohydrate
Lipid
Ash
13.40%
22%
60.40%
2.30% 2.20%
General Components
Water
Protein
Carbohydrate
Lipid
Ash
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Table 1.08: A Comparison of Nutritional value of Chickpea and Dried Peas 
 
  Chickpea, raw Dried pea, raw 
Nutrients Unit Value per 100g Value per 100g 
             Proximates 
Carbohydrates, by 
difference 
g 60.65 60.37 
Fiber, Total dietary g 17.4 25.5 
Protein g 19.30 24.55 
Total Lipid (fat) g 6.04 1.16 
Water g 11.53 11.27 
Energy Kcal 364 341 
Sugars, total g 10.70 8.00 
               Minerals 
Calcium, Ca mg 55 105 
Iron, Fe mg 4.43 6.24 
Magnesium, Mg mg 115 115 
Phosphorus, P mg 366 366 
Potassium, K mg 981 875 
Sodium, Na mg 15 24 
Zinc, Zn mg 3.01 3.43 
               Vitamins 
Vitamin-C mg 1.8 4.0 
Thiamin mg 0.726 0.477 
Riboflavin mg 0.215 0.212 
Niacin mg 2.889 1.541 
Vitamin-B6 mg 0.174 0.535 
Folate, DFE µg 274 557 
Vitamin-B12 µg 0 0 
Vitamin A, RAE µg 7 3 
Vitamin A, IU IU 149 67 
Vitamin E mg 0.09 0.82 
Vitamin D (D2+D3) µg 0 0 
Vitamin D IU 0 0 
Vitamin K µg 14.5 9.0 
               Lipids 
Fatty acids, total 
saturated 
g 0.161 0.626 
Fatty acids, total mono 
unsaturated 
g 0.242 1.358 
Fatty acids, total poly 
unsaturated 
g 0.495 2.694 
Cholesterol mg 0 0 
Source : Agriculture Research Service, United States Department of Agriculture (USDA) 
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1.3 Diabetes and diet 24: 
Eating right is vital if a person is trying to prevent or control diabetes. Even 
though exercise is also important, what the person takes have the biggest impact when it 
comes to weight loss. 
Now-days we hear about carbohydrates all the time. The term “total 
carbohydrate” includes three types of carbohydrates, namely starches, sugars and fibers. 
Starches are also known as complex carbohydrates. Starch rich diet includes peas, split 
peas, black eyed peas, corn, lima beans, pinto beans, kidney beans, dried beans, lentils, 
potatoes and grains like oats, barley and rice. Sugars are referred as simple or fast-acting 
carbohydrates, which includes naturally occurring sugars and added sugars. Fibers are the 
indigestible part of plant foods, including fruits, vegetables, whole grains, nuts and 
legumes. For good health, adults need to try to eat 25 to 30 grams of fiber each day. It is 
important to increase the fiber intake gradually, in order to prevent stomach irritation. 
Carbohydrates have a big impact on your blood sugar levels, so it is very 
important to choose high-fiber, slow release carbohydrate diet. Slow release carbohydrates 
helps to keep your blood sugar levels constant because they are digested more slowly, thus 
preventing your body from producing too much insulin. They also provide lasting energy 
and help you stay full longer. 
 
Table 1.09: Diabetes and diet: 
Choosing carbohydrates that are packed with fibers  
(and don’t spike your blood sugar) 
Instead of Try these high fiber option 
White rice Brown rice or Wild rice 
White potatoes Sweet potatoes, yams, winter squash, 
cauliflower mash 
Regular pasta  Whole-wheat pasta 
White bread Whole-wheat or whole-grain bread 
Sugary breakfast cereal High-fiber breakfast cereal (Raisin Bran, etc.) 
Instant oatmeal Steel-cut oats or rolled oats 
Cornflakes Bran flakes 
Corn Peas or leafy green 
 
The glycemic index (GI) provides a measure that how quickly a food turns into 
sugar in your body. Glycemic load is a newer term which includes both the glycemic index 
and the carbohydrate amount that present in a food, which gives an accurate idea of how a 
food may affect our blood sugar level. High GI foods spike our blood sugar rapidly, while 
low GI foods have the least effect. 
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1.4 Resistant starch 25: 
Resistant starch is the total amount of starch and starch degradation product that 
resists digestion in the small intestine of healthy people. Resistant starch is considered as 
the third type of dietary fiber, as it can deliver some of the benefits of insoluble fiber and 
some of the benefits of soluble fiber. Usually carbohydrates are rapidly digested and 
absorbed as glucose into body through small intestine and subsequently used for short-term 
energy needs or stored. Resistant starch resists digestion and passes to large intestine where 
they act as dietary fibers. 
 
Table 1.10: Resistant starch in Foods: 
Resistant Starch in Foods 
Food Resistant Starch 
(g/100g) 
Chickpeas 10.0 
Beans 5.2 
Corn kernels 3.9 
Red kidney beans 2.6 
Boiled potato (cooled) 2.4 
Oats 1.8 
White bread 0.8 
Whole meal bread 0.8 
Source: CSIRO Division of Human Nutrition, Australia. 
 
Types: 
Resistant starch (RS) has been categorized into 4 types: 
1. RS1: Includes physically inaccessible or digestible resistant starch (found in 
seeds/legumes and unprocessed whole grains). 
2. RS2: Includes starch of natural granular form (uncooked potatoes, green banana 
flour, high amylose corn). 
3. RS3: starch formed when starch containing foods are cooked and cooled such as 
legumes, bread, cornflakes and cooked and chilled potatoes. The process of 
cooking out the starch and cooling is called retrogradation. 
4. RS4: Includes chemically modified starch that resist digestion (have wide variety of 
structure and are not found in nature). 
 
When the resistant starch enters the large intestine, it gets fermented by bacteria 
and forms short-chain fatty acids, which plays a major role in health as mentioned below; 
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Advantages of resistant starch: 
1) Lowers blood glucose level 
2) Lowers blood cholesterol level 
3) Promotes colon health 
4) Prevents colon cancer 
5) Boosts the immune system 
6) Reduces appetite 
7) Increases the amount of fat used for fuel 
8) Helps with weight loss. 
 
In fact, one study exposed that when subjects replaced carbohydrates with 
resistant starch, they had 20% to 30% higher fat oxidation. In particular butyrate (short-
chain fatty acid) appears to block the body’s ability to use carbohydrate as a fuel; which 
responds body to burn more fat instead. Resistant starch may help the people who are at 
risk of diabetes/pre-diabetes by improving insulin sensitivity. Legumes (beans, dried peas, 
lentils) contain the highest amount of the resistant starch. 
1.5 Dosage Forms: 
Drugs are substances that are used in the diagnosis, cure, mitigation, 
prevention/treatment of disease in human beings/animals. Drugs are obtained from 
different sources and are not administered in their pure form. They are converted into 
suitable preparations and then administered to patients; such preparations are known as 
Dosage Forms. Dosage form includes Solid, Semi-solid and Liquid dosage forms. Drug 
substances were frequently administered orally in the type of solid dosage forms as tablets 
and capsules. 
 
1.5.1 Tablets 26: 
Tablets are defined as the compressed solid dosage form having medicaments 
with or without excipients. According to the Indian Pharmacopoeia Tablets are solid, flat / 
biconvex dishes, unit dosage form, prepared by compressing the drugs or the mixture of 
drugs, with or without diluents. They differ in shape and vary greatly in size and weight, 
depending on amount of medicinal substances and the intended mode of administration. It 
is the most accepted dosage form and 70% of the total medicines are dispensed in the form 
of tablet. All medicaments are obtainable in the tablet form except where it is hard to 
formulate or administer. 
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t 
Different types of tablets 26: 
A. Tablets ingested orally: 
1. Compressed tablet 
2. Multiple compressed tablet 
3. Repeat action tablet 
4. Delayed release tablet 
5. Sugar coated tablet 
6. Film coated tablet 
7. Chewable tablet 
B. Tablets used in oral cavity: 
1. Buccal tablet 
2. Sublingual tablet 
3. Torches or lozenges 
4. Dental cone 
C. Tablets administered by other route: 
1. Implantable tablet 
2. Vaginal tablet 
D. Tablets used to prepare solution: 
1. Effervescent tablet 
2. Dispersing tablet 
3. Hypodermic tablet 
4. Tablet triturates 
General properties of tablet dosage forms: 
1) Must have elegant product identity, free from defects like chips, cracks, 
discoloration, and contamination. 
2) Must have sufficient strength to withstand mechanical shock during its production 
packaging, shipping and dispensing. 
3) Must have chemical and physical stability to maintain its physical attributes over 
time. 
4) Must be able to release the medicinal agents in a predictable and reproducible 
manner. 
5) Must have chemical stability ultimately so as not to follow modification of the 
medicinal agents. 
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Advantages of tablet dosage form27: 
1) Unit dosage form, offer greatest capabilities of all oral dosage form for the greatest 
dose precision and least content variability. 
2) Reduced cost of all oral dosage form. 
3) Lighter and compact. 
4) Easy and cheap to pack and strip. 
5) Easy to swallow with least tendency for hang-up. 
6) Sustained release product is achievable by enteric coating. 
7) Bitter taste and objectionable odor can be masked by coating method. 
8) Appropriate for large scale production. 
9) Great chemical, mechanical and microbial stability. 
10)  Product identification is easy. 
Disadvantages of tablet dosage form27: 
1) Difficulty in swallowing incase of children’s and unconscious patients. 
2) Some of the drugs resist compression into dense compacts, owing to amorphous 
nature, low density character. 
3) Drugs with poor wetting, slow dissolution properties, optimum absorption high in 
the gastrointestinal tract may be difficult to formulate as tablet. 
4) Drugs with bitter taste and objectionable odor may require encapsulation or 
coating. In such cases, capsule may offer the best and lowest cost. 
Tablet Ingredients26: 
In addition to active ingredients, tablet contains a number of inert materials 
known as additives or excipients.  
Commonly used excipients are: 
1) Diluents 
2) Binders and adhesives 
3) Disintegrants 
4) Lubricants and glidants 
5) Coloring agents 
6) Flavoring agents 
7) Sweetening agents 
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1) Diluents: 
Diluents are fillers used to make required bulk of the tablet when the drug 
dosage itself is inadequate to produce the bulk. Lactose, dicalcium phosphate, 
calcium sulphate are used as diluents. 
 
2) Binders and adhesives: 
Binders or granulators give cohesiveness to the powdered materials so that the 
powder can be converted in to granules. This ensures that the tablet remains intact 
after compression. Binders are used in the form of solution or in powder form. 
Acacia, starch, starch mucilage, methyl cellulose are commonly used as binders. 
 
3) Disintegrants: 
Disintegrants are substances included in tablet formulation to facilitate the 
disintegration of the tablet after administration. The active ingredients must be 
released from the tablet as efficiently as possible to allow for its dissolution. 
Starches are commonly used as disintegrants. 
 
4) Lubricants and glidants: 
Lubricants are substances which improve the rate of flow of granules, prevent 
adhesion of granules to the surface of the dies and punches and facilitate the 
ejection of tablets from the die cavity. Talc, magnesium stearate, calcium stearate 
are commonly used as lubricants. 
Glidants improves the flow properties of granules from the hopper. Magnesium 
stearate, calcium stearate are used as glidants. 
 
5) Coloring agents: 
It gives elegant appearance to the tablets. Amaranth, tartrazine, sunset yellow 
are used as coloring agent. 
 
6) Flavoring agents: 
It gives good flavor to the tablets. Flavoring agents are mixed with dry granules 
by spraying the flavors on the granules before compression. Volatile oils are used 
as flavoring agents. 
 
7) Sweetening agents: 
It masks the bitter taste of the drug. Dextrose, lactose, mannitol, cyclamates, 
saccharin are used as sweetening agents. 
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1.5.2 Various methods for preparation of tablets 26: 
      Tablets are prepared by three methods namely; 
1. Dry granulation, 
2. Wet granulation, and 
3. Direct compression. 
 
1. Dry granulation: 
Processing steps are:  
Raw material → Weighing → Screen → Mixing → Slugging → Milling → 
Screening → Mixing → Compression. 
When tablet ingredients are sensitive to moisture or unable to withstand 
elevated temperature during drying and when the tablet ingredients doesn’t have 
enough cohesive properties, slugging may be used to form granules. This method is 
referred as dry granulation. 
 
2. Wet granulation: 
Processing steps are:  
         Raw materials → Weighing → Screening → Wet massing → Sieving/Milling 
→ Drying → Screening → Mixing → Compression. 
        The most general and widely used method of tablet preparation is the wet 
granulation method. The active ingredients, diluent and disintegrant are mixed 
thoroughly and the powder mass is wetted with the binding solution until the mass 
has the consistency of damp snow. The wet mass is forced through mesh to obtain 
granules, which is then dried. After drying granulation, the lubricant/glidants are 
added to promote flow of granules. These granules are then compressed to get tablet.  
 
3. Direct compression: 
Processing steps are:  
        Raw material → Weighing → Screening → Mixing → Compression. 
        Direct compression consists of compressing tablets directly from powdered 
materials without modifying physical nature of materials. This method is appropriate 
for crystalline chemicals having good compressible characteristic and flow 
properties. 
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2. LITERATURE REVIEW 
S.No Author’s detail Journal name Objective Conclusion 
01. Luis Fernando 
Polesi et al.,  
 
Brazilian 
Journal of 
Food 
Technology, 
2011; vol. 
14(1): pp no. 
74-81.  
 
Evaluated the 
physicochemical, 
structural and 
functional 
characteristics of 
starches from two 
legumes: green 
pea and chick 
pea.  
 
Pea starch showed 
simple and composite 
granules, B-type 
crystallinity pattern, 
and gelatinization 
peak temperature of 
74.8˚C, reduced 
granule swelling with 
increased temperature 
and did not generate 
high viscosity in 
Rapid Visco Analyzer 
(RVA). Chickpea 
starch showed large 
oval shaped and small 
spherical shaped 
granules, C-type 
crystallinity pattern, 
and gelatinization 
peak temperature of 
64.6˚C, good granule 
swelling and high 
viscosity in the RVA.  
 
02. Emeje Martins 
Ochubiojo et al.,  
 
Scientific, 
Health and 
Social Aspects 
of the Food 
Industry, 2012; 
pp no. 355-
379.  
 
Starch has moved 
from its 
traditional role as 
food to being an 
indispensable 
medicine  
 
Starch has proven to 
be the formulator’s 
“friend” in that, it can 
be utilized in the 
preparation of various 
drug delivery systems 
with the potential to 
achieve the 
formulator’s desire for 
target or protected 
delivery of bioactive 
agents. It is possible to 
conclude that, 
although starch is 
food, it is also 
medicine.  
 
03. Olaf Hausler et 
al.,  
 
www.roquette-
pharma.com  
 
Compared native 
starches such as 
pea starch, maize 
starch and potato 
starch as tablet 
disintegrants.  
 
Pea starch is an 
interesting alternative 
to the widely used 
maize and potato 
starch.  
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04. Kawaljit Singh 
Sandhu, Seung-
Taik Lim 
Carbohydrate 
Polymers 71, 
2008; pp no. 
245-252. 
Evaluated the 
digestibility of 
legume starches 
as influenced by 
their physical and 
structural 
properties. 
Legume starches have 
been reported to have 
lower digestibility as 
compared to cereal 
starches, which makes 
it more suitable for the 
diabetic patients. 
 
05. Daniela 
Mikulikova, Jan 
Kraic 
Journal of 
Food and 
Nutrition 
Research, 
2006; vol. 
45(2): pp no. 
69-76. 
Evaluated Natural 
sources of health-
promoting starch. 
There is more resistant 
and less total starch in 
legumes in 
comparison to cereals 
and pseudo cereals. 
Pea contains the most 
RS3 of all 18 plant-
crops evaluated. 
 
06. Kawaljit Singh 
Sandhu, Seung-
Taik Lim 
Food 
Chemistry 107, 
2008; pp no. 
92–97. 
Evaluated 
structural 
characteristics 
and in vitro 
digestibility of 
Mango 
kernel starches 
Mango kernels wasted 
after industrial 
processing of mango 
could become a useful 
source of starch, 
especially in terms of 
its beneficial 
digestibility 
behavior and high RS 
content. 
 
07. Panuwat 
Dangsungnoen et 
al.,  
 
International 
Proceedings of 
Chemical, 
Biological and 
Environmental 
Engineering, 
2012; vol. 45. 
Compared 
Resistant Starch 
Content and 
Survival of 
Lactobacillus 
spp. on Four 
Different Sources 
of Resistant 
Starch. 
Different sources of 
resistant starch had 
different the resistant 
starch contents  
(p ≤0.05). Cowpea 
flour had lowest level 
of resistant starch 
(6.31%), whereas the 
highest values were 
38.41% found in 
green banana flour. 
 
08. Nednapis 
Vatanasuchart et 
al., 
Maejo 
International 
Journal of 
Science and Te
chnology, 
2012; vol. 
6(2): pp no. 
259-271. 
Evaluated 
Resistant starch 
content, in vitro 
starch 
digestibility and 
physico - 
chemical 
properties of 
flour and starch 
from Thai 
bananas. 
 
The high content of 
RS found in both 
starch and flour 
samples of all six 
cultivars of Thai 
bananas indicates that 
they are a healthy 
choice for 
consumption 
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09. Shiihii su et al.,  Asian Journal 
of 
Pharmaceutical 
and Clinical 
Research, 
2011; vol. 
4(1): pp no. 
22-25. 
Evaluated finger 
millet (Eleusine 
coracana) starch 
as a binder in 
high dose tablets. 
The native Eleusine 
corocana starch when 
used as a binder in 
comparison with 
maize starch, 
competes favorably 
with maize starch. 
 
10. Anuchita 
Moongngarm 
American 
Journal of 
Agricultural 
and Biological 
Sciences, 
2013; vol. 
8(2): 107-113. 
Evaluated 
chemical 
compositions and 
resistant starch 
content in starchy 
foods. 
The legume seeds and 
lesser yam had a high 
concentration of 
protein 
and moderate amount 
of RS, whereas green 
bananas had highest 
amount of RS. 
11. Grelda A. 
Yaiiez-Farias et 
al., 
Starch/starke, 
1997; vol. 
49(9): 341-
345.  
Isolated and 
partially 
characterized 
starches from dry 
beans (Phaseolus 
vulgaris) and 
chick peas (Cicer 
arietinum). 
The isolated starches 
showed oval shaped 
granules and average 
sizes in the range of 
20-25p. The DSC 
results showed that 
pinto bean starch had 
a higher range 
of gelatinization 
temperature and 
higher fusion enthalpy 
than chickpea starch.  
12. Anoop Kumar 
Singh et al., 
International 
Journal of 
Pharmaceutical 
and 
Biomedical 
Research, 
2010, vol. 
1(2): pp no. 
35-41. 
Isolation, 
characterisation 
and formulation 
properties of a 
new plant gum 
obtained from 
Mangifera indica. 
The gum performed as 
a better binding agent 
than Gum Acacia at 
5% w/w. It was also 
found that Mangifera 
indica gum is pH 
sensitive and therefore 
it has a scope in the 
development and 
formulation of 
intestinal drug 
delivery systems. 
13. Gangwar 
Satyam et al., 
International 
Journal of 
PharmTech 
Research, 
2010; vol. 
2(2): pp no. 
1508-1512. 
Isolated and 
Evaluated the 
Binding Property 
of Pappaya Starch 
in Diclofenac 
Sodium Tablet. 
Tablets prepared using 
the pappaya starch as 
binder showed 
significant hardness 
and friability. So it 
can be used as tablet 
binder in 
pharmaceutical 
formulations. 
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14. B. Narkhede 
Sachin et al., 
Journal of 
Chemical and 
Pharmaceutical 
Research, 
2010; vol. 
2(6): pp no.  
161-166. 
Isolation and 
evaluation of 
mucilage of 
Artocarpus 
heterophyllus as a 
tablet binder. 
The tablet 
prepared with 6.0 
%w/v A. heterophyllus 
showed the hardness 
nearly equal to the 
tablet prepared 
by using 6.0 % w/v of 
starch gum 
 
15. P. Rajeev 
Kumar et al., 
Journal of 
Chemical and 
Pharmaceutical 
Research, 
2012; vol. 
4(6): pp no. 
3134-3138. 
Studies on Carica 
papaya starch as a 
pharmaceutical 
excipients. 
Carica papaya starch 
could be used as a 
promising 
pharmaceutical 
excipient in tablet 
technology as, it 
showed adequate 
binding and 
disintegrating 
properties. 
 
16. Bodempudi 
Sravani et al., 
Journal of 
Chemical and 
Pharmaceutical 
Research, 
2011; vol. 
3(2): pp no. 
118-125. 
Studies on Vigna 
mungo Mucilage 
as a 
pharmaceutical 
excipients. 
Vigna mungo (Black 
gram seeds) and can 
be used as an effective 
suspending 
agent and tablet binder 
in oral pharmaceutical 
formulations. 
 
17. M. Marimuthu, 
Krishnamoorthi 
Journal of 
Chemical and 
Pharmaceutical 
Research, 
2013; vol. 
5(5): pp no.  
390-394. 
Evaluated 
Nutrients and 
functional 
properties of 
Macrotyloma 
uniflorum an 
underutilized 
south Indian food 
legume. 
 
Macrotyloma 
uniflorum can be used 
as 
alternative binders 
owing to its 
appreciably values of 
swelling power and 
solubility. 
18. A.R. Oyi et al., Research 
Journal of 
Applied 
Sciences, 
Engineering 
and 
Technology, 
2009; vol. 
1(2): pp no. 
77-80. 
Compared 
Binding Effects 
of Wheat, Rice 
and Maize 
Starches in 
Chloroquine 
Phosphate tablet 
formulations. 
Wheat starch 
formulations give 
stronger tablets in 
comparison to rice and 
standard maize 
starches and this is 
advantageous 
especially when high 
bond strength is 
desired and quick 
disintegration is not 
desirable. 
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19. Singh Akilesh 
Vikram and 
Nath LK 
International 
Journal of 
PharmTech 
Research, 
2009; vol. 
1(2): pp no. 
365-368. 
Evaluated binder 
property of Moth 
bean starch in 
compressed solid 
dosage form. 
Starch obtained from 
Moth bean starch 
possesses better 
binding properties at 
low concentration 
when compared with 
potato starch as 
standard binder. 
20. Jose Antonio 
Garzon Tiznado 
et al., 
Food and 
Nutrition 
Sciences, 
2012; vol. 3, 
pp no. 1281-
1289 
Evaluated 
Acceptability 
Properties and 
Antioxidant 
Potential of Desi 
Chickpea (Cicer 
arietinum L.) 
Cultivars. 
Desi chickpea could 
contribute 
significantly to the 
management and/or 
prevention of 
degenerative diseases 
associated with free 
radical damage. 
21. P. Rajeevkumar 
et al., 
Journal of 
Chemical and 
Pharmaceutical 
Research, 
2010; vol. 
2(4): pp no.  
284-290. 
Investigated 
studies on musa 
paradisiaca 
starch as a 
pharmaceutical 
excipients. 
Musa paradisiaca 
starch could be used 
as a promising 
pharmaceutical 
excipient in tablet 
technology as, it 
showed adequate 
binding and 
disintegrating 
properties. 
 
22. S. Sasanam et 
al., 
World 
Academy of 
Science, 
Engineering 
and 
Technology, 
2011; vol. 57. 
Compared 
resistant starch 
content, and 
pasting properties 
of Cowpeas 
(Vigna 
unguiculata). 
Cowpeas had a 
resistant starch 
content of 4.59- 
10.63%, a solubilized 
starch content of 
29.52-48.18 and a 
total starch content of 
40.15-56.37%. 
23. Patel Shailendra 
et al., 
International 
Journal of 
Pharmaceutical 
& Biological 
Archives, 
2012; vol. 
3(3): pp no. 
466-473. 
Evaluated Natural 
Binding agents in 
tablet 
formulation. 
Natural polymers 
shown good binding 
property in wet 
granulation, granules 
are stable and less 
friable in comparison 
with other binders. 
They can also be used 
to modify the release 
of drug, thereby, 
influencing the 
absorption and 
bioavailability of the 
incorporated drug. 
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3. AIM AND OBJECTIVE 
 
Aim of study: 
 The aim of this study is to evaluate Cicer arietinum and Pisum sativum starch as 
an alternative tablet binder to maize starch by the assessment of preformulation 
and formulation studies. 
Objective of study: 
 To formulate and develop paracetamol tablets by wet granulation technique using 
various concentrations of Cicer arietinum and Pisum sativum starch as binder. 
 To find out the effect of starches on mechanical properties of paracetamol tablet 
formulation. 
 To evaluate the in vitro release profile of paracetamol and evaluate the release 
mechanism on the basis of various kinetic models. 
 To compare the binding capacity, friability, disintegration time and in-vitro drug 
release of the formulation containing isolated starches with that of the 
formulation containing commercially available maize starch. 
 To perform the stability studies of optimized paracetamol formulation. 
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4. PLAN OF WORK 
 
The present work is planned according to the following steps: 
1. Literature survey 
2. Isolation of starch 
3. Preformulation studies of starch 
 Solubility 
 Loss on drying 
 pH determination 
 Angle of repose 
 Bulk density & Tap density 
 Hausner’s index 
 Compressibility index 
 DSC analysis 
 FTIR 
 X-ray powder diffraction 
 Micro structure studies by SEM 
 Phytochemical screening 
 Microbial load 
4. Preformulation studies of Paracetamol 
 Determination of Melting point 
 Solubility 
 Determination of λmax 
 Compatibility studies 
5. Pre-compression evaluation  
 Moisture content 
 Angle of repose 
 Bulk density & tap density 
 Compressibility index 
 Hausner’s ratio 
6. Formulation of Paracetamol tablets 
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7. Post-compression evaluation 
 Thickness 
 Weight variation test 
 Hardness 
 Friability 
 Drug content 
 Disintegration test 
8. In vitro dissolution studies 
9. Release kinetic studies 
10. Stability studies. 
 Drug Profile 
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5. DRUG PROFILE 28, 29 
Generic Name (IP) Paracetamol 
Generic Name (USP) Acetaminophen 
Chemical IUPAC Name N-(4-hydroxyphenyl) acetamide 
Physical properties: 
Structural formula 
 
Molecular formula C8H9SO2 
Molecular weight 151.16 
State Solid 
Melting point 170˚C 
Macroscopic appearance White, crystalline powder. 
Solubility Water              1:70, 
Boiling water   1:20, 
Alcohol            1:10, 
Chloroform      1:50, 
Glycerin           1:40, and 
Slightly soluble in ether. 
Chemical properties: 
Acetaminophen is a synthetic, nonopiate, centrally acting analgesic 
derived from p-aminophenol. The full chemical name is N-acetyl-p-aminophenol. 
PKa 9.51 at 25˚C 
Stability Stable to temperature, light, and moisture. 
pH range over which drug is 
stable in solution. 
Acetaminophen is stable at pH between 4 and 7 at 
25˚C. 
pH of commercially available 
liquid products. 
Acetaminophen oral solution has a pH of 3.8 to 6.1 
and the oral suspension has the pH of 5.4 to 6.9. 
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Clinical pharmacology 
General Generally used for its analgesic and antipyretic 
effects. Its therapeutic effects are similar to 
salicylates, but it lacks anti-inflammatory, 
antiplatelet and gastric ulcerative effects. 
Indication For temporary relief of fever, minor aches, and 
pains. 
Pharmacodynamics 
 
Acetaminophen is widely used as analgesic and 
antipyretic drug which is used for the relief of fever, 
headaches, and other minor aches and pains. At 
therapeutic doses acetaminophen does not irritate 
the lining of the stomach nor affect blood 
coagulation, kidney function, or the fetal ductus 
arteriosus (as NSAIDs can). Like NSAIDs and 
unlike opioid analgesics, acetaminophen does not 
cause euphoria or alter mood in any way.  
 
Mechanism of action Acetaminophen is thought to act primarily in the 
CNS, increasing the pain threshold by inhibiting 
both isoforms of cyclooxygenase, COX-1, COX-2, 
and COX-3 enzymes involved in prostaglandin 
(PG) synthesis.  
 
Absorption Rapid and almost complete. 
Protein binding 25% 
Half life  1 to 4 hours 
Elimination Approximately 80% of acetaminophen is excreted 
in the urine after conjugation and about 3% is 
excreted unchanged. 
Category Antipyretics  
Analgesic, Non-Narcotic. 
Food interactions Avoid alcohol (may increase risk of hepatotoxicity) 
and take without regard to meals. 
Affected organisms Humans and other mammals. 
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Dosage range For adults and children 12 years of age and older, 
the recommended dose of acetaminophen is 650 to 
1000 mg every 4 to 6 hours as needed, not to 
exceed 4000 mg in 24 hours. 
For children under 12 years of age, the 
recommended dose of acetaminophen is 10 to 15 
mg/kg every 4 to 6 hours, not to exceed five doses 
(50-75 mg/kg) in 24 hours 
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6. EXCIPIENT’S PROFILE 30 
6.1 Lactose: 
Table 6.01: Physico-chemical characteristics of Lactose 
Synonyms Lactosum anhydricum; lattosio; Lactopress 
anhydrous; milk sugar; saccharum lactis. 
Empirical Formula  C12H22O11  
Molecular weight 342.30 
Structural Formula 
 
Description White to off-white crystalline particles or 
powder, it is odorless and slightly sweet taste. 
Functional Category Directly compressible tablet excipients; dry 
powder inhaler carrier; lyophilization aid; 
tablet and capsule diluent; tablet and capsule 
filler. 
Solubility  Soluble in water; sparingly soluble in ethanol 
(95%) and ether. 
Moisture Content Anhydrous lactose contain 1%w/w of water, 
Lactose monohydrate contains 5%w/w of 
water. 
Melting Point 223.0˚C for anhydrous -lactose;  
252.2˚C for anhydrous -lactose;  
232.0˚C for commercial anhydrous lactose. 
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True density 1.589g/cm3 for anhydrous -lactose 
Bulk density 0.71g/cm3 
Tapped density 0.88g/cm3 
Stability and Storage conditions Stored in a well-closed container in a cool, dry 
place. 
Incompatibilities Incompatible with strong oxidizers, 
Incompatible with amino acids, 
aminophylline, amphetamine and lisinopril. 
Safety Adverse reactions to lactose are largely due to 
lactose intolerance, which occurs in 
individuals with a deficiency of the intestinal 
enzyme lactase. 
Application Anhydrous lactose is widely used in direct 
compression tableting applications, and as a 
tablet and capsule filler and binder. Anhydrous 
lactose can be used with moisture-sensitive 
drugs due to its low moisture content. It may 
also be used in intravenous injections. 
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6.2 Starch: 
Table 6.02: Physico-chemical characteristics of Starch 
Synonyms Amido; amidon; amilo; amylum; Eurylon; 
fecule; maydis amylum; solani amylum. 
Empirical Formula  (C6H10O5)n where n=300-1000. 
Structural Formula 
 
Description Odorless and tasteless, fine, white to off-white 
powder. It consists of very small spherical or 
ovoid granules.  
Functional Category Tablet and capsule diluent; tablet and capsule 
disintegrant; tablet binder; thickening agent. 
Solubility  Practically insoluble in cold ethanol (96%) and 
in cold water, Soluble in hot water above the 
gelatinization temperature. 
Acidity/alkalinity pH 4.0-8.0 
Amylose content 24-28% for corn starch 
True density 1.478g/cm3 for corn starch 
Bulk density 0.45-0.58g/cm3 for corn starch 
Tapped density 0.69-0.77g/cm3 for corn starch 
Gelatinization temperature 71˚C for corn starch 
Swelling temperature 64˚C for corn starch 
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Moisture Content 12% for corn starch 
Particle size distribution Corn starch: 2-32µm; average particle diameter 
13µm. 
Stability and Storage conditions Stored in an airtight container in a cool, dry 
place. 
Incompatibilities Starch is incompatible with strongly oxidizing 
substances. Colored inclusion compounds are 
formed with iodine. 
Safety Allergic reactions to starch are extremely rare 
and individuals apparently allergic to one 
particular starch may not experience adverse 
effects with a starch from a different botanical 
source. The wheat proteins (gluten) are 
problematic for conditions such as celiac 
disease. Contamination of surgical wounds with 
the starch glove powder used by surgeons has 
resulted in the development of granulomatous 
lesions. 
Application Starch is a versatile excipients used primarily in 
oral solid-dosage formulations where it is 
utilized as a binder, diluent, and disintegrant. 
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6.3 Talc: 
Table 6.03: Physico-chemical characteristics of Talc 
Synonyms Hydrous magnesium silicate; powdered talc; 
Purified French chalk; soapstone; steatite; 
talcum. 
Empirical Formula  Mg6(Si2O5)4(OH)4 
Description Very fine, white to grayish-white, odorless, 
impalpable, unctuous, crystalline powder. 
Readily adheres to the skin and is soft to 
touch and free from grittiness. 
Functional Category Anticaking agent; glidant; tablet and capsule 
diluent; tablet and capsule lubricant. 
Solubility  Practically insoluble in dilute acids and 
alkalis, organic solvents, and water. 
Acidity/alkalinity pH 7-10 for a 20% w/v aqueous dispersion. 
pH 7.0-9.0 
Stability and Storage conditions Talc is a stable material and may be sterilized 
by heating at 160˚C for not less than 1 hour. 
Talc should be stored in a well-closed 
container in a cool, dry place. 
Incompatibilities Incompatible with quaternary ammonium 
compounds. 
Application Talc was once widely used in oral solid 
dosage formulations as a lubricant and 
diluent, today it is less commonly used. 
However, it used as a dissolution retardant in 
the controlled-release products. Talc is also 
used as a lubricant in tablet formulation; in a 
novel coating for extended-release pellets; 
and as an adsorbent. In topical preparations, 
talc is used as a dusting powder.  
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6.4 Magnesium stearate: 
Table 6.04: Physico-chemical characteristics of Magnesium stearate. 
Synonyms Dibasic magnesium stearate; magnesium salt; 
magnesium distearate; octadecanoaic acid; 
octadecanoate; synpro 90. 
Empirical Formula  C36H70MgO4 
Molecular weight 591.24 
Structural Formula [CH3(CH2)16COO]2Mg 
Description Very fine, light white, precipitated or milled, 
impalpable powder of low bulk density, 
having a faint odor, the powder is greasy to 
touch and readily adheres to the skin. 
Functional Category Tablet and capsule lubricant. 
Solubility  Practically insoluble in ethanol, ether and 
water; Slightly soluble in warm benzene and 
warm ethanol. 
Flowability Poorly flowing, cohesive powder. 
Melting Point 117-150˚C 
True density 1.092g/cm3 
Bulk density 0.159g/cm3 
Tapped density 0.286g/cm3 
Stability and Storage conditions Stable and should be stored in a well-closed 
container in a cool, dry place. 
Incompatibilities Incompatible with strong acids, alkalis, and 
iron salts. 
Safety Oral consumption of large quantities may 
produce a laxative effect or mucosal irritation. 
Application Used in cosmetics, food & pharmaceutical 
formulations and as a lubricant in capsule & 
tablet at concentration between 0.25-5.0%.  
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7. MATERIALS AND METHODS 
 
7.1 MATERIALS 
Table 7.01 List of Materials used: 
 
S.No MATERIALS SOURCES 
01. PARACETAMOL GRANULES INDIA LIMITED 
02. MAIZE STARCH CAPLIN POINT LABORATORIES 
03. LACTOSE CAPLIN POINT LABORATORIES 
04. MAGNESIUM STEARATE CAPLIN POINT LABORATORIES 
05. TALC CAPLIN POINT LABORATORIES 
06. METHYL PARABEN KMCH LABORATORY 
07. PROPYL PARABEN KMCH LABORATORY 
 
Table 7.02 List of Instruments used: 
 
S.No INSTRUMENTS MANUFACTURERS 
01. FT/IR SPECTROSCOPY/4100 JASCO 
02. HYDRAULIC/PELLET PRESS KIMAYA ENGINEERS 
03. UV  SPECTROPHOTOMETER SYSTRONICS 
04. BULK & TAPPED DENSITY 
APPARATUS C-TDA2 
CAMPBELL ELECTRONICS 
 
05. ROCHE FRIABILATOR CAMPBELL ELECTRONICS 
06. TABLET COMPRESSION 
MACHINE 
REMIK MINIPRESS/II MT 
AHMEDABAD. 
07. WEIGHING BALANCE BL 220H SCHIMADZU 
08. HOT AIR OVEN TECHINO 
09. HARDNESS TESTER TAB MACHINE 
10. TABLET DISINTEGRATION 
APPARATUS 
TAB MACHINE 
 
11. DISSOLUTION APPARATUS TAB MACHINES, MUMBAI 
12. pH METER EUTECH 
13. B.O.D INCUBATOR TECHINO, CHENNAI 
14. COLONY COUNTER DEEP VISION 
15. STABILITY CHAMBER TECHINO, MUMBAI. 
16. VERNIER CALIPER ABSOLUTE DIGIMATIC, 
MITUTOYO 
17. SEM JSM 9390 JEOL, JAPAN 
18. DSC DSC Q20 V24.2 Build 107 
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7.2 METHODS 
 
   7.2.1 Preformulation studies of Cicer arietinum and Pisum sativum starch: 
Preformulation studies were performed on the Cicer arietinum and Pisum 
sativum starch, which includes isolation, purification and physicochemical 
characterization of starches. 
 
   7.2.2 Isolation and Purification of Cicer arietinum and Pisum sativum starch: 
 
 Isolation of Cicer arietinum and Pisum sativum starch31: 
 
Process Flow chart: 
 
Starch source (Cicer arietinum/Pisum sativum): collected 
 
Soaked in water (5-6 hours) & outer covering (seed coat) is removed 
 
Wet milled & dough is collected 
 
Mix 1 portion of dough with 4 portions of water 
 
Filtration (8-fold muslin cloth) 
 
    Residue (Add 4 parts of water)                     (Continue until no more starch separates                                         
                                                                                                     out) 
Filtrate collected 
                                                          (Allow to settle for 2-3 hours) 
Starch sediments (due to high density) 
                                                         Supernant liquid removed 
Starch washing  
 
Starch dewatering 
 
Starch drying (Hot air oven: 50-60˚C) for 1-2 hours 
                                   (Grind in mortar) 
Starch Powder (fines) 
 
Sieving (Mesh no: 100) 
 
Packed: Air tight containers 
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 Appearance of Cicer arietinum & Pisum sativum used in this study: 
 
              
      Figure 7.01: Cicer arietinum                       Figure 7.02: Pisum sativum 
 
 
 Separation of starch from Cicer arietinum & Pisum sativum in this study: 
 
Figure 7.03: Separation of starch from Cicer arietinum slurry 
 
Figure 7.04: Separation of starch from Pisum sativum slurry 
 
 Purification of Cicer arietinum & Pisum sativum starch31: 
To Starch powder add 0.08 M NaOH slowly 
                                                                                 To promote flocculation of proteins 
pH adjusted to 7.6 using pH paper 
                                                       Supernant was discarded 
Decanted Starch re-suspended in distilled water 
                                                                         Repeat starch washing & dewatering 
Starch is dried, powdered, sieved and packed. 
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   7.2.3 Physicochemical characterization of Cicer arietinum and Pisum sativum starch: 
            1.  Solubility test 
The separated starches were evaluated for solubility in water, ethanol and 
hot water in accordance with the pharmacopoeial monograph specification. 
 
            2.  Loss on drying 
0.2g of powder sample was dried in an oven at 105˚C until a constant 
weight was obtained. The moisture content was then determined as the ratio of 
weight of moisture loss to weight of sample expressed as a percentage. 
 
            3.  pH determination 
This was done by 1% w/v dispersion of the sample in water and the pH 
was determined using a digital pH meter. 
 
            4.  Angle of repose 
The angle of repose, θ, was measured according to the fixed funnel and 
standing cone method. A funnel was clamped with its tip 2 cm above a graph paper 
placed on a flat horizontal surface. The sample was carefully poured through the 
funnel until the apex of the cone touches the tip of the funnel. The diameter of the 
sample base was noted and the tangent of the angle of repose was calculated using 
the equation. 
𝑡𝑎𝑛𝜃 =
2ℎ
𝐷
 
 
            5.  Bulk and tap densities 
10g of powder sample was placed in a 50ml measuring cylinder and the 
volume, V0, occupied by each sample without tapping was noted. After 1000 taps, 
the occupied volume V1000 was noted. The bulk and tap densities were calculated as 
the ratio of weight to volume. 
𝐵𝑢𝑙𝑘 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 =
𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑡ℎ𝑒 𝑠𝑎𝑚𝑝𝑙𝑒
𝐵𝑢𝑙𝑘 𝑣𝑜𝑙𝑢𝑚𝑒
 
𝑇𝑎𝑝 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 =
𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑡ℎ𝑒 𝑠𝑎𝑚𝑝𝑙𝑒
𝑇𝑎𝑝 𝑣𝑜𝑙𝑢𝑚𝑒
 
 
            6.  Hausner’s index 
Hausner’s index of the sample was calculated by the ratio of tapped 
density to bulk density. 
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𝐻𝑎𝑢𝑠𝑛𝑒𝑟′𝑠 𝑟𝑎𝑡𝑖𝑜 =
𝑇𝑎𝑝 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
𝐵𝑢𝑙𝑘 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
 
 
            7.  Compressibility index 
Compressibility index indicates powder flow properties, and was 
calculated using the equation.  
𝐶𝑎𝑟𝑟′𝑠 𝑖𝑛𝑑𝑒𝑥 =
𝑇𝑎𝑝 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 − 𝐵𝑢𝑙𝑘 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
𝑇𝑎𝑝 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
× 100 
 
            8.  Differential scanning calorimetric (DSC) analysis  
Thermal properties of the sample were characterized using DSC. Nitrogen 
at the rate of 20ml/min was used as purge gas; 1.0000 mg of powdered material 
were sealed in an aluminium pan and heated from 20˚C up to 200˚C at the rate of 
10˚C/min. A graph was generated for each sample; peak, onset, offset and enthalpy 
were calculated. 
 
            9. Fourier transform infra red (FT-IR) 
The FT-IR spectrum of the sample was recorded in Jasco FT/IR 4100 
spectrometer, using potassium bromide (KBr) discs prepared from powdered 
samples mixed with dry KBr. Measurements were made from scanning range of 
4000 to 400 cm-1  and the spectrum with the clearest identifiable peaks was chosen. 
The IR spectra of the isolated starches were compared to that of the standard maize 
starch and the interactions were analyzed. 
 
            10. X-ray powder diffraction (XRD)31 
X-ray diffraction of the starches were analyzed using a X-ray 
diffractometer. Powder samples were packed in rectangular aluminium cells and 
illuminated using CuK radiation (λ=1.00000 A˚) at 40 kV and 30 mA. Samples 
were scanned between different angles of 4˚ to 90˚C 2θ. Scan speed of 5.0000 
(deg/min) was used and the preset time was 1.20 (sec). A nickel filter was used to 
reduce the K contribution to the X-ray signal. The ‘d’ spacing’s were computed 
according to Bragg’s law of diffraction and measurements were made at ambient 
temperature. 
 
            11. Microstructure studies by SEM31 
Morphological features of the starches were studied with a JSM 9390 
scanning electron microscope of JEOL, Japan. The dried sample was mounted on a  
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metal stub and sputtered with gold in order to make the sample conductive, and the 
images were taken at an accelerating voltage of 5 kV with different magnifications. 
 
            12. Phytochemical screening of starch samples 
Preliminary tests were performed to verify the nature of starch obtained. 
The chemical tests such as Molisch’s test, Ferric chloride test, Keller-killaini test, 
Wagner’s test, Salkowski test, Foam test, shinoda test, Biuret test and Iodine test 
were performed and reported. 
 
            13. Microbial load for starch samples32, 33 and 34 
Spread plate method was used to cultivate 1ml of starch samples solution 
on Muller Hilton Agar Medium for enumeration of bacteria and Sabouraud 
Dextrose Agar Medium for fungi. 
 
 
                  Muller Hilton Agar Medium: 
1.52 gm of Muller Hilton agar medium with 1gm of agar was dissolved in 
40ml of distilled water. Then it is sterilized by autoclaving at 121˚C for 15min. 
20ml of the medium was poured in each plate.  By serial dilution method, 1gm of 
starch sample dissolved in 10ml hot water, five serial dilutions were made with 
distilled water. 1ml of starch solution was spread on the plate and incubated at 37˚C 
for 72 hours. At the end of incubation period, the bacterial colonies formed were 
counted by colony counter. 
 
Sabouraud Dextrose Agar Medium: 
2.60 gm of Sabouraud Dextrose agar medium with 1gm of agar was 
dissolved in 40ml of distilled water. Then it is sterilized at 121˚C for 15min. 20ml 
of the medium was poured in each plate.  By serial dilution method, 1gm of starch 
sample dissolved in 10ml hot water, five serial dilutions were made with distilled 
water. 1ml of starch solution was spread on the plate and incubated at 27˚C for 72 
hours. At the end of incubation period, the fungal colonies formed were counted by 
colony counter. 
 
   7.2.4 Preformulation studies of paracetamol 
Preformulation studies were performed on the drug, which includes 
melting point determination, solubility and compatibility studies.  
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            1. Determination of melting point 
By Capillary method, melting point of paracetamol was determined. 
Previously sealed capillary tube on one end was taken and filled with fine powder 
of paracetamol which is then placed in melting point apparatus. The temperature at 
which the paracetamol powder melts was noticed. 
 
            2. Solubility 
Solubility of drug was determined in ethanol, and acetone. Solubility 
studies were done by taking excess amount of drug in different beakers containing 
the solvents. The mixtures were shaken at regular intervals for 24 hrs and filtered 
using whattmann’s filter paper. The filtered solutions were analyzed 
spectrophotometrically at 243nm.  
 
            3. Determination of λmax 
Paracetamol solution containing the concentration of 0.1µg/ml was 
prepared with 0.1 N HCl and UV spectrum was taken using UV spectrophotometer. 
The solution was scanned in the range of 200-400nm. 
 
a) Preparation of standard calibration curve of paracetamol 
100mg of Paracetamol was weighed accurately and transferred into 100ml 
volumetric flask. 0.1N HCl was added to dissolve and made up to the volume to 
give the stock solution containing 1000µg/ml. From the standard stock solution, 
10ml solution was diluted with 100ml 0.1N HCl (100µg/ml). Appropriate aliquots 
were taken into different volumetric flask and made up to 100ml with 0.1N HCl so 
as to get five different concentrations (0.2, 0.4, 0.6, 0.8, 1.0µg/ml). The UV 
absorbance were measured by UV spectrophotometer at 243nm using 0.1N HCl as 
a blank. Beer-Lambert curve was drawn and correlation coefficient was calculated. 
 
            4. Compatibility studies 
The FT-IR spectrum of the sample was recorded in Jasco FT/IR 4100 
spectrometer, using potassium bromide (KBr) discs prepared from powdered 
samples mixed with dry KBr. Measurements were made from scanning range of 
4000 to 400 cm-1  and the spectrum with the clearest identifiable peaks was chosen. 
The IR spectra of the pure drug and pure excipients were compared to that of the 
mixture of drug & excipients and the interactions were analyzed. 
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 7.2.5 Formulation of paracetamol tablets 
 
Table 7.03 Paracetamol formulations containing different starch as binder. 
(For 1 tablet) 
 
Ingredients 
(mg) 
Formulations 
2.5% Binder 5% Binder 7.5% Binder 10% Binder 
Paracetamol 500 500 500 500 
Binder 16.25 32.5 48.75 65 
Starch 32.5 32.5 32.5 32.5 
Lactose 87.275 71.025 54.775 38.525 
Magnesium stearate 6.5 6.5 6.5 6.5 
Talc 6.5 6.5 6.5 6.5 
Methyl paraben 0.65 0.65 0.65 0.65 
Propyl paraben 0.325 0.325 0.325 0.325 
Total 650 650 650 650 
 
Table 7.04 Paracetamol formulations containing Cicer arietinum starch as binder. 
(For 100 tablets) 
 
Ingredients 
(mg) 
F1 F2 F3 F4 
2.5% Binder 5% Binder 7.5% Binder 10% Binder 
Paracetamol 50,000 50,000 50,000 50,000 
Cicer arietinum starch 1625 3250 4875 6500 
Starch 3250 3250 3250 3250 
Lactose 8727.5 7102.5 5477.5 3852.5 
Magnesium stearate 650 650 650 650 
Talc 650 650 650 650 
Methyl paraben 65 65 65 65 
Propyl paraben 32.5 32.5 32.5 32.5 
 
Table 7.05 Paracetamol formulations containing Pisum sativum starch as binder. 
(For 100 tablets) 
 
Ingredients 
(mg) 
F5 F6 F7 F8 
2.5% Binder 5% Binder 7.5% Binder 10% Binder 
Paracetamol 50,000 50,000 50,000 50,000 
Pisum sativum starch 1625 3250 4875 6500 
Starch 3250 3250 3250 3250 
Lactose 8727.5 7102.5 5477.5 3852.5 
Magnesium stearate 650 650 650 650 
Talc 650 650 650 650 
Methyl paraben 65 65 65 65 
Propyl paraben 32.5 32.5 32.5 32.5 
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Table 7.06 Paracetamol formulations containing Zea mays starch as binder. 
(For 100 tablets) 
Ingredients 
(mg) 
F9 F10 F11 F12 
2.5% Binder 5% Binder 7.5% Binder 10% Binder 
Paracetamol 50,000 50,000 50,000 50,000 
Zea mays starch 1625 3250 4875 6500 
Starch 3250 3250 3250 3250 
Lactose 8727.5 7102.5 5477.5 3852.5 
Magnesium stearate 650 650 650 650 
Talc 650 650 650 650 
Methyl paraben 65 65 65 65 
Propyl paraben 32.5 32.5 32.5 32.5 
 
Wet granulation Method: 
By wet granulation technique the granules of different formulation was 
prepared by using paracetamol IP as model drug. The binder concentrations used were 2.5, 
5.0, 7.5 & 10% w/w. By reducing the level of lactose in the formula the binder level was 
adjusted. All the ingredients are dry mixed in the mortar and water is used as the 
granulating fluid. Wet mass was granulated manually in 12 mesh sieve and granules were 
dried at 60˚C for 1hr in hot air oven. The dried granules were passed through sieve no. 22, 
after adding lubricants they were compressed by using Remik minipress/II MT with flat 
faced punches. Tablet formulation was developed for 650 mg tablet weight.  
 
   7.2.6 Pre-compression evaluation 
 
            1. Moisture content 
Moisture content of the granules was determined by taking 5gm of 
granules from each batch and heating it in an oven at 120˚C for 1 hour. The 
granules were weighed immediately; from the loss in weight the moisture content 
was calculated.  
 
            2. Determination of angle of repose 
The angle of repose of the granules was determined by the funnel method. 
The weighed granules were taken in the funnel. The height of the funnel was 
adjusted in such a way that the tip of the funnel just touches the apex of the 
granules. The granules were allowed to flow freely and the diameter of the granules 
cone was measured and angle of repose was calculated using the following 
equation. 
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𝑡𝑎𝑛 𝜃 =
ℎ
𝑟
 
𝜃 = 𝑡𝑎𝑛−1 ( 
ℎ 
𝑟
) 
                                                    Where; θ = angle of repose 
                                                                 h = height of the cone 
                                                                 r = radius of the cone 
 
                    Table 7.07 Flow property and corresponding angle of repose 
 
Flow property Angle of repose 
Excellent 25-30 
Good 31-35 
Fair 36-40 
Passable 41-45 
Poor 46-55 
 
            3. Determination of bulk and tapped density 
Initially Loose bulk density (LBD) and Tapped bulk density (TBD) was 
determined. 20gm of granules from each formula was weighed accurately and 
introduced in to 50ml measuring cylinder. After that the initial volume was noted, 
tapping was continued to obtain tapped volume (continued until no further change 
in volume is noted). 
 
𝐿𝐵𝐷 =
𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑡ℎ𝑒 𝑝𝑜𝑤𝑑𝑒𝑟
𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑔𝑟𝑎𝑛𝑢𝑙𝑒 𝑝𝑎𝑐𝑘𝑖𝑛𝑔 𝑏𝑒𝑓𝑜𝑟𝑒 𝑡𝑎𝑝𝑝𝑖𝑛𝑔
 
 
𝑇𝐵𝐷 =
𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑡ℎ𝑒 𝑝𝑜𝑤𝑑𝑒𝑟
𝑇𝑎𝑝𝑝𝑒𝑑 𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑔𝑟𝑎𝑛𝑢𝑙𝑒 𝑝𝑎𝑐𝑘𝑖𝑛𝑔
 
 
            4. Compressibility index 
The compressibility index of the granules was calculated from the 
difference between the tap and bulk densities divided by tap density and the ratio 
expressed as a percentage. 
 
𝐶𝑎𝑟𝑟′𝑠 𝑖𝑛𝑑𝑒𝑥 =
𝑇𝑎𝑝 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 − 𝐵𝑢𝑙𝑘 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
𝑇𝑎𝑝 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
× 100 
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            5. Hausner’s ratio 
Hausner’s ratio was calculated by dividing the tap density by bulk density 
of the granule. 
𝐻𝑎𝑢𝑠𝑛𝑒𝑟′𝑠 𝑟𝑎𝑡𝑖𝑜 =
𝑇𝑎𝑝 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
𝐵𝑢𝑙𝑘 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
 
 
           Table 7.08 Scale of flowability 
 
Compressibility index 
(%) 
Flow character Hausner’s ratio 
≤ 10 Excellent 1.00-1.11 
11-15 Good  1.12-1.18 
16-20 Fair 1.19-1.25 
21-25 Passable 1.26-1.34 
26-31 Poor 1.35-1.45 
32-37 Very poor 1.46-1.59 
 
   7.2.7 Post-compression evaluation of paracetamol tablets 
 
            1. Thickness  
Thickness of the tablets was determined by vernier calipers. 5 tablets were 
used and the average was taken. 
 
            2. Weight variation test 
20 tablets of each formulation were weighed using a balance and test was 
performed according to the official method. 20 tablets selected randomly and 
weighed individually to check weight variation. 
 
        Table 7.09 Table Specification for tablets weight variation (as per USP) 
 
Average weight of tablets (mg) Percent deviation 
130 or less 10 
130-324 7.5 
More than 324 5 
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            3. Hardness test 
Three tablets were randomly picked and the hardness was determined by 
Pfizer tablet hardness tester. It is expressed in kg/cm2. 
 
            4. Friability test 
Friability of the tablet was determined by using Roche Friabilator. It is 
expressed in percentage (%). 10 tablets were initially weighed and transferred in 
to friabilator, which was operated at 25rpm for 4 minutes. The tablets are 
weighed again and the % friability was calculated. The % friability of tablets less 
than 1% are considered acceptable. 
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑓𝑟𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 =
(𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑤𝑒𝑖𝑔ℎ𝑡 − 𝑓𝑖𝑛𝑎𝑙 𝑤𝑒𝑖𝑔ℎ𝑡)
𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑤𝑒𝑖𝑔ℎ𝑡
× 100 
 
            6. Drug content 
5 tablets were individually weighed and powdered, powder equivalent to 
average weight was weighed and drug was extracted in acetone and the drug 
content was determined by measuring the absorbance at 243nm after suitable 
dilution using UV-pharmspec-1700, Shimadzu. 
 
            7. Disintegration test35 
6 tablets were placed in a disintegration tester (camp-bell electronics, 
Mumbai), filled with distilled water at 37˚C±0.20C. When all the particles of the 
tablet passes through the wire mesh the disintegration time was recorded by the 
mean of two determinations. 
 
 
   7.2.8 In vitro dissolution studies35 
The release rate of paracetamol from tablets was performed with USP 
specifications using (Tab machine) six stage dissolution rate apparatus 
(BP/IP/USP) paddle type. The dissolution test was performed using 900ml of 0.1 N 
HCl at 37˚C and 50 rpm. Sample of the solution was withdrawn from the 
dissolution apparatus, and replaced with fresh dissolution medium. Sample was 
diluted with 0.1N HCl to get a suitable concentration. Solutions absorption was 
measured at 243 nm using UV spectrophotometer. Cumulative percentage of drug 
release was calculated by means of the equation obtained from the standard curve. 
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   7.2.9 Release kinetics38 
When a novel solid dosage form is developed, there is the need to make 
sure that drug dissolution occurs in an appropriate manner. In such case, drug’s 
dissolution of solid dosage form has been described by various kinetic models (zero 
order, first order and higuchi kinetics). In order to study the release kinetics, data’s 
obtained from in-vitro drug release studies were plotted in various kinetic models; 
1.  Zero order:                % cumulative drug release Vs time  
              C = K0t 
2.  First order:             log % cumulative drug remains Vs time 
               Log C = Log C0 – Kt / 2.303 
3.  Higuchi’s model:           Mt/M∞ Vs Square root time 
The drug release data for the various tablets that formulated was 
graphically evaluated for their regression coefficient values. From the regression 
coefficient data’s, the values that found to be nearest 1 follow the appropriate order 
of kinetics. 
   7.3.0 Stability studies 
Stability study provides proof that how a drug substance/drug product’s 
quality varies with the influence of wide range of environmental factors. 
Accelerated stability study was carried out in stability chamber, in accordance with 
ICH guidelines; Best fit formulation was selected and evaluated for the following 
stability study. 
Parameters: 
Type: Accelerated Condition 
Testing conditions: 40˚C ± 2˚C/ 75%RH ± 5%RH 
Sampling: Initial, 3rd month and 6th month 
 
Evaluated parameters: 
1. Physical appearance, 
2. Hardness (kg/cm2), 
3. Friability (%), 
4. Drug content (%), 
5. Disintegration time (minutes), and 
6. Dissolution (%CR in 120 min). 
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8. RESULTS AND DISCUSSION 
 
8.1 PREFORMULATION STUDIES OF STARCH: 
 
8.1.1 Isolation and purification of Cicer arietinum and Pisum sativum starch: 
 
            
     Figure 8.01: Cicer arietinum                       Figure 8.02: Pisum sativum 
            
      Figure 8.03: Cicer arietinum starch           Figure 8.04: Pisum sativum starch 
 
         Yield Obtained: 
 
Table 8.01 Yield obtained from starch rich sources 
 
S.No Source Amount used Yield Obtained 
01. Cicer arietinum L. 1 Kg 36.21% 
02. Pisum sativum L. 1 Kg 34.59% 
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8.1.2 Physiochemical properties of Cicer arietinum and Pisum sativum starch: 
 
Table 8.02 Physiochemical properties of Cicer arietinum and Pisum sativum starch 
 
S.No Parameters Cicer arietinum starch Pisum sativum starch 
01. Description Fine, white powder Fine, white powder 
02. Odour  Odourless  Odourless 
03. Taste Tasteless Tasteless 
04. Solubility Insoluble in water and  
95% ethanol  
Insoluble in water and  
95% ethanol 
05. Loss on drying 6.24% 5.98% 
06. Bulk density (g/cc) 0.52 0.52 
07. Tapped density (g/cc) 0.71 0.71 
08. Compressibility index 26.30% 26.30% 
09. Hausner’s ratio 1.35 1.35 
10. Angle of repose 52.22˚ 54.05˚ 
11. pH 7.55 7.61 
 
DSC 
Parameters 
Instrument used: DSC Q20 v24.2 Build 107 
Temperature range: 20˚C to 200˚C 
Rate: 10˚C/min 
 
 
 Cicer arietinum starch                                    Pisum sativum starch
   
 
Figure 8.05: DSC results of Cicer arietinum starch and Pisum sativum starch 
 
Table 8.03 DSC characteristics of Cicer arietinum and Pisum sativum starch 
 
S.No. Starch Tp (˚C) ∆H (Jg-1 starch) 
01. Cicer arietinum starch 127.55˚C 1026 J/g 
02. Pisum sativum starch 129.89˚C 1416 J/g 
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FT-IR of isolated starches: 
 
Figure 8.06: IR spectrum of Cicer arietinum starch 
 
Figure 8.07: IR spectrum of Pisum sativum starch 
 
Figure 8.08: IR spectrum comparison of Cicer arietinum, Pisum sativum & Zea mays 
starch. 
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XRD 
 
 
Figure 8.09: X-ray diffraction pattern of Cicer arietinum starch 
 
 
Figure 8.10: X-ray diffraction pattern of Pisum sativum starch 
 
 
Table 8.04 X-ray diffraction characteristics of Cicer arietinum and Pisum sativum starch 
 
 
S.No Starch 
Peak 1 Peak 2 Peak 3 
Intensity 
(counts) 
Bragg 
angle (˚2θ) 
Intensity 
(counts) 
Bragg 
angle (˚2θ) 
Intensity 
(counts) 
Bragg 
angle (˚2θ) 
01. Cicer arietinum 
starch 
663 16.8000 548 23.0000 251 33.1000 
02. Pisum sativum 
starch 
656 17.2000 552 23.0000 264 33.1000 
 
The X-ray pattern of the laboratory isolated Cicer arietinum starch and Pisum 
sativum starch revealed C-type starch X-ray pattern. This was characterized by strong 
intensity peaks corresponding approximately to 17˚, 23˚ and 33˚. The exact values of peak 
position of legume starches are shown in the table above. 
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SEM 
 
Cicer arietinum starch: 
 
    
    
Figure 8.11: Cicer arietinum starch viewed by SEM under various magnifications 
Pisum sativum starch: 
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Figure 8.12: Pisum sativum starch viewed by SEM under various magnifications. 
 
Table 8.05 SEM observation of Cicer arietinum starch and Pisum sativum starch 
 
 
 
S.No 
 
Starch (SEM) 
 
Current observations 
Granule 
size(µm) 
01. 
Cicer arietinum 
starch 
 
Ellipsoidal, spherical (small granules) 
 
9-20µm 
02. Pisum sativum 
starch 
Rounded but irregular shapes, some of 
the smaller granules appeared to be 
ellipsoidal and spherical (simple and 
composite granules). 
12-30µm 
 
8.1.3 Phytochemical screening of Cicer arietinum and Pisum sativum starch: 
Table 8.06 Phytochemical test of Cicer arietinum and Pisum sativum starch 
 
S.No 
 
Chemical test 
Cicer arietinum 
starch 
Pisum sativum 
starch 
01. Test for Carbohydrates  + + 
02. Test for Alkaloids - - 
03. Test for Steroids & sterols - - 
04. Test for Glycosides - - 
05. Test for Saponins - - 
06. Test for Flavonoids - - 
07. Test for Tannins & phenolic compounds - - 
08. Test for Proteins & amino acids + + 
09. Test for Starch + + 
  (+) = Present and (-) = Absent 
 
8.1.4 Microbial load of Cicer arietinum and Pisum sativum starch: 
Spread plate method was used to cultivate the isolated starch samples 
solution on Muller Hilton agar medium for enumeration of bacteria and Sabouraud 
Dextrose agar medium for fungi. After the incubation period, the bacterial & fungal 
colonies formed were counted. 
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Bacterial growth 
         
    Figure 8.13: Cicer arietinum starch                Figure 8.14: Pisum sativum starch 
Fungal growth 
         
   Figure 8.15: Cicer arietinum starch               Figure 8.16: Pisum sativum starch 
 
Table 8.07 Microbial load of Cicer arietinum starch and Pisum sativum starch 
 
S.No 
 
Starch sample Bacterial growth 
(No. of colonies) 
Fungal growth 
(No. of colonies) 
01. Cicer arietinum starch 96 CFU 222 CFU 
02. Pisum sativum starch 75 CFU 273 CFU 
 
The Cicer arietinum and Pisum sativum starches were from the natural 
source and hence microbial load test was done. The results show that the bacterial 
and fungal growth obtained was under the limit specified by united state 
pharmacopoeia. 
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8.2 PREFORMULATION STUDIES OF PARACETAMOL: 
8.2.1 Solubility: 
Solubility of pure drug in solvents were carried out and found to be soluble in 
acetone, ethanol and insoluble in water. 
 
8.2.2 Melting point: 
Melting point of pure drug was found to be 169˚C. 
 
8.2.3 Determination of λmax for paracetamol: 
The λmax of paracetamol was found to be 243 or 244 nm. 
 
Figure 8.17: UV absorption spectrum of paracetamol 
 
8.2.4 Calibration curve of paracetamol: 
The absorbance data’s for calibration curve of paracetamol at 243 nm. 
 
Table 8.08 Absorbance data for calibration curve of paracetamol 
 
S.No Concentration (µg/ml) Absorbance in 0.1M HCl 
01. 0.2 0.155 
02. 0.4 0.291 
03. 0.6 0.436 
04. 0.8 0.575 
05. 1.0 0.740 
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      Figure 8.18: Standard calibration curve of paracetamol in 0.1N HCl 
 
A Calibration curve for paracetamol was done in 0.1N HCl by scanning 
the proper diluted drug solution at 243nm using UV spectrophotometer. The linearity 
of the calibration curve was found to be in the range of 0.2-1.0µg/ml. A regression 
coefficient value of 0.999 was noticed for paracetamol. 
 
8.2.5 Compatibility studies: 
The drug excipients compatibility study was done by using Jasco FT/IR 
spectrometer. The IR spectra for pure drug, excipients and drug-excipients mixture 
were shown in the following figures. 
 
 
Figure 8.19: IR spectrum of paracetamol 
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Figure 8.20: IR spectrum of Cicer arietinum starch 
 
 
Figure 8.21: IR spectrum of Pisum sativum starch 
 
 
Figure 8.22: IR spectrum of Zea mays starch 
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Figure 8.23: IR spectrum of Combination (Paracetamol + Cicer arietinum starch) 
 
 
 
Figure 8.24: IR spectrum of Combination (Paracetamol + Pisum sativum starch) 
 
 
 
Figure 8.25: IR spectrum of Combination (Paracetamol + Zea mays starch) 
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Figure 8.26: IR spectrum of pure drug, excipients and combination 
 
The spectrum of the drug-excipients mixture was found to be a mere 
summation of the individual spectrum of the drug and excipients which suggest that 
there were no interaction and were compatible with each other. 
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Interpretation of FT-IR spectrums 
 
Table 8.09 Interpretation of FT-IR spectrum of pure drug, excipients and combination 
 
S.No Samples 
Reported peaks 
(cm-1) 
Observed peak 
(cm-1) 
Inference 
 
 
 
01. 
 
 
 
Paracetamol 
3400-3200 3326.35 O-H stretching 
3500-3100 3160.76 N-H stretching 
1655-1620 1652.7 C=O (amide) 
stretching 
1570-1515 1564.95 Amide II band 
1250 1259.29 C-N-H group 
850-750 836.95 Para-disubstituted 
aromatic ring 
 
02. 
 
Cicer arietinum 
Starch 
3400-3200 3230.18 O-H Stretching 
2950-2850 2925.48 C-H Stretching 
1645 1645.95 H-O-H Bending 
 
03. 
 
Pisum sativum 
Starch 
3400-3200 3213.79 O-H Stretching 
2950-2850 2926.45 C-H Stretching 
1645 1635.34 H-O-H Bending 
 
04. 
 
Zea mays  
Starch 
3400-3200 3245.61 O-H Stretching 
2950-2850 2926.45 C-H Stretching 
1645 1638.23 H-O-H Bending 
 
 
05. 
 
 
Combination 
3500-3100 3161.72 N-H stretching 
1655-1620 1654.62 C=O (amide) 
stretching 
1250 1259.29 C-N-H group 
850-750 836.95 Para-disubstituted 
aromatic ring 
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8.3 PRE-COMPRESSION EVALUATION OF PARACETAMOL TABLETS: 
8.3.1 Moisture content: 
           Moisture content of the prepared granules of paracetamol was found to be 3%.  
 
8.3.2 Determination of densities and related properties: 
Table 8.10 Densities and related properties of paracetamol granules 
 
Formulations Bulk 
density 
(g/ml) 
Tapped 
density 
(g/ml) 
Hausner’s 
ratio 
Carr’s index 
(%) 
Angle of repose 
(degrees) 
F1  0.4347  0.4819  1.1085  09.79  34.59  
F2  0.4310  0.4796  1.1127  10.13  35.06  
F3  0.4301  0.4796  1.1150  10.32  35.22  
F4  0.4296  0.4807  1.1189  10.63  35.21  
F5  0.4329  0.4761  1.0997  09.07  33.98  
F6  0.4310  0.4784  1.1099  09.90  34.28  
F7  0.4301  0.4784  1.1122  10.09  34.43  
F8  0.4301  0.4796  1.1150  10.32  34.28  
F9  0.4329  0.4761  1.0997  09.07  33.68  
F10  0.4310  0.4784  1.1099  09.90  34.74  
F11  0.4310  0.4807  1.1153  10.33  35.05  
F12  0.4301  0.4807  1.1176  10.52  34.89  
 
8.4 POST-COMPRESSION EVALUATION OF PARACETAMOL TABLETS: 
Table 8.11 Post-compression evaluation of paracetamol tablets 
 
Formulations Compression 
force (KN) 
Tablet 
thickness 
Weight 
variation  
Hardness 
(kg/cm2) 
Friability 
(%) 
Drug 
content 
(%) 
F1  30  4.28mm  651±2 mg  02.76  0.41  100.12  
F2  30  4.29mm  652±2 mg 03.08  0.33  99.97  
F3  30  4.31mm  652±2 mg 03.22  0.36  100.10  
F4  30  4.35mm  654±2 mg 03.46  0.29  99.65  
F5  30  4.31mm  653±3 mg 02.60  0.44  99.92  
F6  30  4.32mm  651±4 mg 02.78  0.38  99.47  
F7  30  4.35mm  651±3 mg 02.86  0.35  100.23  
F8  30  4.41mm  653±2 mg 03.00  0.27  99.95  
F9  30  4.29mm  652±2 mg 02.80  0.47  100.03  
F10  30  4.30mm  653±3 mg 03.06  0.39  99.63  
F11  30  4.35mm  652±3 mg 03.14  0.34  99.87  
F12  30  4.42mm  652±4 mg 03.36  0.30  99.89  
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Table 8.12 Disintegration time of paracetamol tablets containing different binder 
concentrations 
 
Binder 
Concentrations 
Disintegration time 
Cicer arietinum 
starch 
Pisum sativum 
starch 
Zea mays  
starch 
2.5%  (F1)  02 min.19 sec  (F5)  01 min.59 sec   (F9)   02 min.20 sec  
5%  (F2)  07 min.13 sec  (F6)  03 min.53 sec (F10)  05 min.43 sec 
7.5%  (F3)  10 min.37 sec  (F7)  05 min.40 sec  (F11)  08 min.29 sec  
10%  (F4)  12 min.54 sec  (F8)  08 min.03 sec  (F12)  11 min.22 sec  
 
8.5 DRUG RELEASE PROFILE STUDIES: 
8.5.1 In-vitro drug release data of paracetamol tablets: 
Parameters: 
Dissolution medium           0.1N HCl (900ml) [USP] 
Method                               Paddle method 
Temperature                       37 ± 0.5˚C 
Speed                                  50 rpm 
Time                                   120 minutes 
Absorbance                        243 nm 
 
Table 8.13 Cumulative drug release of paracetamol tablets containing different binder 
concentrations 
 
 
 
 
 
 
 
 
TIME 
(Min)  
% Cumulative drug release of  different concentrations of paracetamol formulations 
Cicer arietinum starch  Pisum sativum starch  Zea mays starch  
F1 
(%) 
F2 
(%) 
F3 
(%) 
F4 
(%) 
F5 
(%) 
F6 
(%) 
F7 
(%) 
F8 
(%) 
F9 
(%) 
F10 
(%) 
F11 
(%) 
F12 
(%) 
10 38.07 23.16 26.02 23.16 32.59 31.69 31.06 36.76 24.49 27.48 27.89 29.49 
20 46.52 45.36 40.19 35.94 57.62 58.39 57.27 41.22 54.21 52.41 53.68 39.78 
30 65.36 57.63 55.46 44.78 66.73 67.98 66.83 49.62 63.32 61.11 62.37 54.34 
40 73.72 65.34 63.32 57.03 75.90 76.96 75.72 60.19 70.67 71.9 69.74 61.48 
50 81.66 72.73 72.77 63.11 83.71 82.61 82.67 67.73 77.85 78.99 79.06 65.09 
60 89.43 80.53 80.14 72.34 91.01 85.01 90.93 75.94 87.55 88.29 87.55 74.57 
90 94.61 89.28 88.71 81.28 96.69 95.67 93.74 86.81 95.61 93.73 94.53 83.31 
120 - 95.12 92.37 88.16 - 98.68 96.49 93.73 - 97.47 95.08 92.87 
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Table 8.14 Cumulative drug release of paracetamol tablets containing 2.5% binder 
concentration 
TIME (Min) 
% Cumulative drug release of 2.5% starch as Binder 
Cicer arietinum 
starch 
(F1) 
Pisum sativum starch 
(F5) 
Zea mays starch 
(F9) 
10 38.07  32.59  24.49  
20 46.52  57.62  54.21  
30 65.36  66.73  63.32  
40 73.72  75.90 70.67  
50 81.66  83.71  77.85  
60 89.43  91.01  87.55  
90 94.61  96.69  95.61  
120 38.07  32.59  24.49  
 
 
Figure 8.27: Dissolution profile of prepared paracetamol formulations using 2.5% 
binder 
 
Table 8.15 Cumulative drug release of paracetamol tablets containing 5% binder 
concentration 
TIME (Min) 
% Cumulative drug release of 5% starch as Binder 
Cicer arietinum 
starch 
(F2) 
Pisum sativum starch 
(F6) 
Zea mays starch 
(F10) 
10 23.16  31.69  27.48  
20 45.36  58.39  52.41  
30 57.63  67.98  61.11  
40 65.34  76.96  71.90  
50 72.73  82.61  78.99  
60 80.53  85.01  88.29  
90 89.28  95.67  93.73  
120 95.12  98.68  97.47  
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Figure 8.28: Dissolution profile of prepared paracetamol formulations using 5% 
binder 
 
Table 8.16 Cumulative drug release of paracetamol tablets containing 7.5% binder 
concentration 
TIME (Min) 
% Cumulative drug release of 7.5% starch as Binder 
Cicer arietinum 
starch 
(F3) 
Pisum sativum starch 
(F7) 
Zea mays starch 
(F11) 
10 26.02  31.06  27.89  
20 40.19  57.27  53.68  
30 55.46  66.83  62.37  
40 63.32  75.72  69.74  
50 72.77  82.67  79.06  
60 80.14  90.93  87.55  
90 88.71  93.74  94.53  
120 92.37  96.49  95.08  
 
 
Figure 8.29: Dissolution profile of prepared paracetamol formulations using 7.5% 
binder 
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Table 8.17 Cumulative drug release of paracetamol tablets containing 10% binder 
concentration 
TIME (Min) 
% Cumulative drug release of 10% starch as Binder 
Cicer arietinum 
starch 
(F4) 
Pisum sativum starch 
(F8) 
Zea mays starch 
(F12) 
10 23.16  36.76  29.49  
20 35.94  41.22  39.78  
30 44.78  49.62  54.34  
40 57.03  60.19  61.48  
50 63.11  67.73  65.09  
60 72.34  75.94  74.57  
90 81.28  86.81  83.31  
120 88.16  93.73  92.87  
 
 
Figure 8.30: Dissolution profile of prepared paracetamol formulations using 10% 
binder 
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8.5.2 Dissolution characteristics of paracetamol tablets: 
Table 8.18 Dissolution characteristics of paracetamol tablets 
Binder Formulation 
Binder 
conc. 
(%w/w) 
Time 
(min) 
% 
cumulative 
release 
T50 
(min) 
T80 
(min) 
Regression 
coefficient  
r2 
 
Cicer 
arietinum 
starch 
F1 2.5% 90  94.61  22.94  48.98  0.871  
F2 5% 90  89.28  26.02  59.60  0.873  
F3 7.5% 90  88.71  27.04  59.89  0.901  
F4 10% 90  81.28  35.07  88.58  0.931  
 
Pisum 
sativum 
starch 
F5 2.5% 90  96.69  17.35  47.78  0.837  
F6 5% 90  95.67  17.12  48.42  0.816  
F7 7.5% 90  93.74  17.46  48.38  0.801  
F8 10% 90  86.81  33.23  82.93  0.964  
  
Zea mays 
   starch 
F9 2.5% 90  95.61  18.44  54.82  0.843  
F10 5% 90  93.73  19.08  54.36  0.849  
F11 7.5% 90  94.53  18.62  54.82  0.859  
F12 10% 90  83.31  27.60  86.42  0.918  
 
8.5.3 Release kinetics of paracetamol tablets: 
Table 8.19 Release kinetics of paracetamol tablets 
Binder Formulation 
Binder conc. 
(%w/w) 
Zero order 
(r2)  
First order 
(r2)  
Higuchi 
kinetics 
(r2)  
 
Cicer 
arietinum 
starch 
F1 2.5% 0.816  0.978  0.975  
F2 5% 0.858  0.993  0.980  
F3 7.5% 0.876  0.993  0.986  
F4 10% 0.902  0.988  0.988  
 
Pisum 
sativum 
starch 
F5 2.5% 0.799  0.992  0.970  
F6 5% 0.782  0.987  0.963  
F7 7.5% 0.782  0.957  0.960  
F8 10% 0.867  0.986  0.969  
  
Zea mays 
starch 
F9 2.5% 0.833  0.987  0.970  
F10 5% 0.830  0.983  0.974  
F11 7.5% 0.831  0.990  0.976  
F12 10% 0.857  0.988  0.990  
 
The regression coefficient value for First order equation was found to be 
near to 1 revealing that the dissolution profile of the formulations may follow “First order 
kinetics”. 
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Figure 8.31: Zero order kinetics profile of prepared paracetamol formulations 
containing 2.5% binder 
 
 
 
Figure 8.32: Zero order kinetics profile of prepared paracetamol formulations 
containing 5% binder 
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Figure 8.33: Zero order kinetics profile of prepared paracetamol formulations 
containing 7.5% binder 
 
 
 
Figure 8.34: Zero order kinetics profile of prepared paracetamol formulations 
containing 10% binder 
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Figure 8.35: First order kinetics profile of prepared paracetamol formulations 
containing 2.5% binder 
 
 
 
Figure 8.36: First order kinetics profile of prepared paracetamol formulations 
containing 5% binder 
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Figure 8.37: First order kinetics profile of prepared paracetamol formulations 
containing 7.5% binder 
 
 
 
Figure 8.38: First order kinetics profile of prepared paracetamol formulations 
containing 10% binder 
 
 
y = -0.0105x + 1.97
R² = 0.9934
y = -0.0134x + 1.9138
R² = 0.9574
y = -0.014x + 1.988
R² = 0.990
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
0 20 40 60 80 100
Lo
g 
%
 C
u
m
u
la
ti
ve
 d
ru
g 
re
m
ai
n
s
Time (minutes)
Cicer arietinum
Pisum sativum
Zea mays
Linear (Cicer
arietinum)
Linear (Pisum
sativum)
Linear (Zea mays)
First order kinetics 7.5% Binder
y = -0.0079x + 1.9604
R² = 0.9889
y = -0.0089x + 1.9369
R² = 0.9865
y = -0.008x + 1.9179
R² = 0.9882
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
0 20 40 60 80 100
Lo
g 
%
 C
u
m
u
la
ti
ve
 d
ru
g 
re
m
ai
n
s
Time (minutes)
Cicer arietinum
Pisum sativum
Zea mays
Linear (Cicer
arietinum)
Linear (Pisum
sativum)
Linear (Zea mays)
First order kinetics 10% Binder
 Results and Discussion 
Department of Pharmaceutics, KMCH College of Pharmacy, Coimbatore. Page 71 
 
 
 
 
 
Figure 8.39: Higuchi kinetics profile of prepared paracetamol formulations 
containing 2.5% binder 
 
 
 
Figure 8.40: Higuchi kinetics profile of prepared paracetamol formulations 
containing 5% binder 
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Figure 8.41: Higuchi kinetics profile of prepared paracetamol formulations 
containing 7.5% binder 
 
 
 
Figure 8.42: Higuchi kinetics profile of prepared paracetamol formulations 
containing 10% binder 
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Figure 8.43: Best fit kinetic release profile of formulation (F2).  
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8.6 Stability studies of paracetamol tablets: 
Table 8.20 Stability studies of paracetamol tablets 
Stability study of formulation F2 (5% Cicer arietinum starch) 
Condition : 40˚C ± 2˚C/ 75%RH ± 5%RH (Accelerated) 
S.No Parameters Initial 3rd  month 6th  month 
01. Physical appearance White  White  White  
02. Hardness 03.08 kg/cm2  03.12 kg/cm2  03.10 kg/cm2  
03. Friability 0.33%  0.27% 0.31% 
04. Drug content 99.97%  99.99%  100.04%  
05. Disintegration time 07 min & 13 
sec  
08 min & 37 
sec  
07 min & 54 sec  
 
06. 
Dissolution 
(%CR in 120 min) 
 
95.12%  
 
94.33%  
 
94.81%  
 
Stability studies were done as per ICH guidelines. The formulation was kept at 
accelerated condition for the period of six months and evaluated during third and sixth 
month for their physical appearance, hardness, friability, drug content, disintegration and 
dissolution. The studies were done and the results show that the tablets were stable at 
room temperature. 
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9. SUMMARY AND CONCLUSION 
SUMMARY 
 
The Preformulation studies were performed on the Cicer arietinum and Pisum 
sativum starch, which includes isolation, purification and physicochemical characterization 
of starches (including XRD, SEM, and DSC). Physicochemical characterization of starches 
shows that it has poor flow property, where XRD results show that the laboratory isolated 
Cicer arietinum starch and Pisum sativum starch revealed C-type starch X-ray pattern. 
SEM observation of Cicer arietinum starch shows ellipsoidal, spherical granules of size 
range 9-20µm and Pisum sativum starch shows rounded, irregular granules of size range 
12-30µm. As Cicer arietinum and Pisum sativum starches were from the natural source, 
microbial load test was done using pour plate method. The result shows that the bacterial 
and fungal growth obtained were under the limit specified by USP. 
 
Compatibility studies were done by using FTIR, the examined spectra of pure 
drug, polymers and combination reveals that there is no significant interaction between 
drug and polymers.  
 
Four formulations were made for each binder using different concentrations 
(2.5%, 5%, 7.5%, and 10%), three different binders were used to formulate twelve 
formulations and evaluated. The efficiency of various binders was studied by wet 
granulation technique. The prepared granules were evaluated for the pre-compression 
studies like moisture content, angle of repose, bulk density, tapped density, compressibility 
index and Hausner’s ratio. The results show that it has good flow property and 
compression characteristics suitable for compression.  
 
The paracetamol tablets prepared were evaluated for the post-compression 
studies like thickness, weight variation, hardness, friability, drug content, disintegration 
and in-vitro dissolution studies. The obtained results show that all the twelve formulations 
were under the specified limits as stated in the Pharmacopoeial monograph. 
 
Among twelve formulations, formulation F2 (5% Cicer arietinum starch) shows 
good binding capacity (hardness), decrease in friability and slow disintegration with slow 
drug release in comparison with commercially available binder like Zea mays starch. 
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Release kinetics of paracetamol tablets were done and the regression 
coefficient value for first order equation was found to be near to 1 revealing that the 
dissolution profile of the formulations may follow “First order kinetics”. 
Stability studies were done as per ICH guidelines. The formulation was kept at 
accelerated condition for the period of six months and evaluated during third and sixth 
month for their physical appearance, hardness, friability, drug content, disintegration and 
dissolution. The studies were done and the results show that the tablets were stable at room 
temperature. 
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CONCLUSION 
 
Resistant starch is the total amount of starch and starch degradation product that 
resists digestion in the small intestine of healthy people, passes to large intestine where 
they act as dietary fibers. Resistant starches studies exposed that when carbohydrates are 
replaced by resistant starch they had 20 to 30% higher fat oxidation. In particular 
resistant starch appears to block the body’s ability to use carbohydrate as a fuel. 
Therefore resistant starch may help the people who are at the risk of diabetes/pre-
diabetes by improving insulin sensitivity. 
These suggested that Cicer arietinum starch could be an useful binding agent 
especially where high mechanical strength and slower release concern. 
Our studies concluded that Cicer arietinum starch (resistant starch) can be used 
as an appropriate binder in any anti-diabetic drug formulations.  
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ABSTRACT  
In the present study, we evaluated pharmaceutical properties of the novel starch 
isolated from the seeds of Cicer arietinum and Pisum sativum to assess its functionality as 
pharmaceutical binder in tablet formulations. 
The isolated starches were subjected for pre-formulation studies (including DSC, 
SEM and XRD), where the physicochemical characterization of starches showed poor flow 
property. Compatibility studies confirmed that there was no significant interaction between 
drug and polymers. Microbial load test showed that the bacterial and fungal growth was 
under the limit specified.  
Efficiency of various binders were studied by wet granulation technique. Four 
formulations were made for each binder using different concentrations (2.5%, 5%, 7.5%, 
and 10%), three different binders used to formulate twelve formulations. Pre-compression 
studies of granules exhibited good flow property and compression characteristics suitable 
for compression. The formulated tablets were evaluated for post-compression parameters.  
It was found that tablets with Cicer arietinum starch showed good binding capacity 
(hardness), friable within limit and slow disintegration with slow drug release in comparison 
with commercially available binder like Zea mays starch. Release kinetics reveals that the 
drug release might follow “First order kinetics”. Stability studies were done as per ICH 
guidelines and the tablets were found to be stable. 
These findings suggested that Cicer arietinum starch could be an useful binding 
agent especially where high mechanical strength and slower release concern. 
Our studies concluded that Cicer arietinum starch (resistant starch) can be used 
as an appropriate binder in any anti-diabetic drug formulations. 
Key words: Resistant starch, Cicer arietinum, Pisum sativum, Natural binder, Starch, 
Natural excipients, Paracetamol, Tablets and Anti-diabetic formulations. 
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